The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(pentan-3-yl)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)benzo[d]isoxazol-6-amine ID: ALA4552309
PubChem CID: 134190210
Max Phase: Preclinical
Molecular Formula: C18H19N5O
Molecular Weight: 321.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCC(CC)c1noc2cc(Nc3n[nH]c4cccnc34)ccc12
Standard InChI: InChI=1S/C18H19N5O/c1-3-11(4-2)16-13-8-7-12(10-15(13)24-23-16)20-18-17-14(21-22-18)6-5-9-19-17/h5-11H,3-4H2,1-2H3,(H2,20,21,22)
Standard InChI Key: HMFKVZFDBCKKGJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
27.3167 -20.6815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3156 -21.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0236 -21.9100 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0218 -20.2726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7304 -20.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7352 -21.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5153 -21.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9926 -21.0798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5075 -20.4205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7723 -22.5207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5726 -22.6859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8244 -23.4617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9072 -22.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1083 -22.0757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1681 -23.0163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6271 -23.6283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0419 -24.3320 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8393 -24.1549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9172 -23.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6212 -22.9268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3326 -23.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6138 -22.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3177 -21.6946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3400 -24.1461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 2 0
12 16 1 0
15 13 1 0
13 14 2 0
14 11 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
19 20 1 0
20 21 1 0
20 22 1 0
22 23 1 0
21 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 321.38Molecular Weight (Monoisotopic): 321.1590AlogP: 4.75#Rotatable Bonds: 5Polar Surface Area: 79.63Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.88CX Basic pKa: 2.54CX LogP: 4.15CX LogD: 4.15Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.55Np Likeness Score: -1.24
References 1. Bollinger SR, Engers DW, Panarese JD, West M, Engers JL, Loch MT, Rodriguez AL, Blobaum AL, Jones CK, Thompson Gray A, Conn PJ, Lindsley CW, Niswender CM, Hopkins CR.. (2018) Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu4 )., 62 (1): [PMID:30247901 ] [10.1021/acs.jmedchem.8b00994 ]